机译:沙利度胺抑制Graves眼病的眼眶成纤维细胞成脂
Department of Endocrinology and Metabolism, Hangzhou First People’s Hospital, Nanjing Medical University, Xueshi Road 4#, Hangzhou City, 310006, Zhejiang Province, China;
Department of Endocrinology and Metabolism, Hangzhou First People’s Hospital, Nanjing Medical University, Xueshi Road 4#, Hangzhou City, 310006, Zhejiang Province, China;
Department of Endocrinology and Metabolism, Hangzhou First People’s Hospital, Nanjing Medical University, Xueshi Road 4#, Hangzhou City, 310006, Zhejiang Province, China;
Department of Endocrinology and Metabolism, Hangzhou First People’s Hospital, Nanjing Medical University, Xueshi Road 4#, Hangzhou City, 310006, Zhejiang Province, China;
Department of Endocrinology and Metabolism, Hangzhou First People’s Hospital, Nanjing Medical University, Xueshi Road 4#, Hangzhou City, 310006, Zhejiang Province, China;
Department of Endocrinology and Metabolism, Ha;
Graves’ ophthalmopathy; Adipogenesis; Thalidomide; TSHR; PPARγ;
机译:沙利度胺抑制Graves眼病的眼眶成纤维细胞成脂
机译:壳聚糖抑制Graves眼病的眼眶成纤维细胞发炎和成脂
机译:辛伐他汀下调Graves眼病患者的3T3-L1前脂肪细胞和眼眶成纤维细胞的脂肪生成
机译:坟墓的轨道减压坟墓眼镜疗法:犹豫不决与平衡内侧加侧壁技术
机译:沙利度胺类似物:血管生成和人类癌细胞增殖的双重抑制剂。
机译:功能性增强的胎盘衍生的间充质干细胞抑制曲目成纤维细胞的脂肪发生坟墓眼科病变
机译:功能性增强的胎盘衍生的间充质干细胞抑制曲目成纤维细胞的脂肪发生,坟墓眼科病变
机译:致畸代谢:沙利度胺和沙利度胺类似物对抑制细胞附着于刀豆蛋白涂层塑料表面的产物的活化。经过修改的版本